Navigation Links
Dr. Fischer Said It Will Notify Pediatricians That Its Baby Eyelid Wipes Are Available At U.S. Pharmacies Contrary To What A Competitor Is Saying In Advertising About Its Wipes For Babies Being The 'First And Only' In The U.S. Market
Date:8/13/2012

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Dr. Fischer, the global pharmaceutical company based in Israel, said today it will send a letter to Pediatricians, Ophthalmologists and Pharmacists notifying them that its baby eyelid wipes have been available for some time at U.S. pharmacies contrary to what an eye-care competitor is saying in advertising about its baby eyelid & eyelash cleanser being the "first and only" such wipes in the U.S. market.

Not only does it plan to correct the record, but Dr. Fischer will take the opportunity also to point out that no one can miss its brand and world famous logo in pharmacies and that its eye-care wipes for babies individually are not only a superior product according to many pediatricians, but even much larger in size than the competitor's brand. 

"Dr. Fischer's baby eyelid wipes have been available at U.S. pharmacies since December 2008," said Tom Madden, CEO of  Dr. Fischer's public relations firm in the U.S., TransMedia Group (www.transmediagroup.com).   

"The Dr. Fischer eye-care for babies product started out on a small scale at private pharmacies and since June of this year distribution and sales have expanded significantly as more and more pediatricians and pharmacists started recommending Dr. Fischer Baby Eye-Care Wipes as well as other Dr. Fischer eye-care products," Madden said.

"All that Dr. Fischer is seeking to do is to make it known that there is not only one, but two eyelid wipes for children on the market and that Dr. Fischer's product has been available for some time," Madden said. 

"There's no reason why competitors can't compete amicably as long as that what they say about the market is accurate."

About Fischer Pharmaceuticals

Fischer Pharmaceuticals is a world leader in the development and manufacture of advanced health care preparations in the fields of dermatology, opthalmology and nutraceuticals.

The company's innovative R&D continually sets trends and norms in the industry, utilizing its' medical know-how with advanced pharmaceutical technology to offer consumers the best of both worlds; science and nature.

Media contact: Donna Balancia, 561-750-9800 x223 or donna@transmediagroup.com


'/>"/>
SOURCE Fischer Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
3. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
5. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
6. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
7. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
8. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Cytomedix, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ... ... valued at US$ 7,167.6 Mn in 2015, and is expected ... CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... Bloom Burton & Co. Healthcare Investor Conference 2017 at the Sheraton ... Edward Wright , Chief Executive Officer of the Company is scheduled ... CFO, Richard Bear and the Chairman of the Board, ... ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... ... 2017 , ... “Reflections of God’s Work”: an enlightening collection of life lessons ... creation of published author, Jerri Broglin, a survivor of great loss who gained insight ... great eye-opener for those searching for answers, as we are finding the answers that ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist ... 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held ... its annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a ... systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has ... the product advances towards regulatory and clinical phases. , "This is another important ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
Breaking Medicine News(10 mins):